
Bioorganic and Medicinal Chemistry Letters p. 703 - 708 (1999)
Update date:2022-08-03
Topics:
Shen, Wang
Fakhoury, Stephen
Donner, Greg
Henry, Kenneth
Lee, Jang
Zhang, Haichao
Cohen, Jerry
Warner, Robert
Saeed, Badr
Cherian, Sajeev
Tahir, Stephen
Kovar, Peter
Bauch, Joy
Ng, Shi-Chung
Marsh, Kennan
Sham, Hing
Rosenberg, Saul
Synthesis and biological evaluation of heteroarenes as reduced cysteine replacements are described. Of the heteroaryl groups examined with respect to FT inhibitor FTI-276 (1), pyridyl was the replacement found to be most effective. Substitutions at C4 of the pyridyl moiety did not affect the in vitro activity. Compound 9a was found to have moderate in vivo bioavailability.
View MoreHangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
Kunming Biohome Technology Co. Ltd.
website:http://www.biohometech.com/
Contact:86-871-67428869
Address:kunming
Contact:+8613400661290
Address:No 908,Kangwan Rd, Liuyang Economic
Shanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Doi:10.1039/b109301k
(2002)Doi:10.1515/bchm2.1973.354.1.659
(1973)Doi:10.1021/ic50132a045
(1974)Doi:10.1021/jm00330a031
(1965)Doi:10.1016/S0957-4166(01)00515-8
(2001)Doi:10.3987/COM-09-S(E)2
(2010)